Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DYRK1A | Q13627 | 3/20 | 0.45 |
| ▸ | SLC13A5 | Q86YT5 | 1/20 | 0.43 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.42 |
| ▸ | LOX | P28300 | 1/20 | 0.42 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.42 |
| ▸ | LRRK2 | Q5S007 | 2/20 | 0.41 |
| ▸ | AAK1 | Q2M2I8 | 4/20 | 0.41 |
| ▸ | S1PR1 | P21453 | 2/20 | 0.41 |
| ▸ | FAAH | O00519 | 1/20 | 0.40 |
| ▸ | ACVR2A | P27037 | 1/20 | 0.40 |
| ▸ | TGFBR2 | P37173 | 1/20 | 0.40 |
| ▸ | CNR1 | P21554 | 1/20 | 0.39 |
| ▸ | MAPK13 | O15264 | 1/20 | 0.39 |
| ▸ | MAPK12 | P53778 | 1/20 | 0.39 |
| ▸ | MAPK11 | Q15759 | 1/20 | 0.39 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.39 |
| ▸ | WNT3A | P56704 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17413864 | 0.85 | DYRK1A (0.44) | DYRK1ASLC13A5CHRNA7LOXLOXL2 | |
| SCHEMBL16116782 | 0.83 | LOX (0.55) | DYRK1ASLC13A5CHRNA7LOXLOXL2 | |
| SCHEMBL30626327 | 0.83 | LOX (0.55) | DYRK1ASLC13A5CHRNA7LOXLOXL2 | |
| SCHEMBL13036116 | 0.82 | DYRK1A (0.55) | DYRK1ASLC13A5CHRNA7LOXLOXL2 | |
| SCHEMBL6632692 | 0.80 | LOX (0.48) | DYRK1ALOXLOXL2LRRK2S1PR1 | |
| SCHEMBL29141734 | 0.80 | DYRK1A (0.53) | DYRK1ASLC13A5CHRNA7LOXLOXL2 | |
| SCHEMBL22283952 | 0.79 | HSD17B1 (0.49) | DYRK1ASLC13A5CHRNA7LOXLOXL2 | |
| SCHEMBL16404625 | 0.78 | CNR1 (0.49) | DYRK1ASLC13A5LOXLOXL2LRRK2 | |
| SCHEMBL22295862 | 0.76 | AAK1 (0.47) | DYRK1ASLC13A5CHRNA7LOXLOXL2 | |
| SCHEMBL17504882 | 0.75 | LOX (0.44) | DYRK1ASLC13A5CHRNA7LOXLOXL2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11629129-B2 | Microbiocidal picolinamide derivatives | SYNGENTA PARTICIPATIONS AG (CH) | 2023-04-18 | — | — | US | disclosed |
| US-20210114984-A1 | MICROBIOCIDAL PICOLINAMIDE DERIVATIVES | SYNGENTA PARTICIPATIONS AG (CH) | 2021-04-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210114984-A1 | MICROBIOCIDAL PICOLINAMIDE DERIVATIVES | PRF1, CASP1, MSR1 | DYRK1A 3770/4885SLC13A5 2573/4885CHRNA7 3124/4885 |
| US-11629129-B2 | Microbiocidal picolinamide derivatives | PRF1, CASP1, MSR1 | DYRK1A 3770/4885SLC13A5 2573/4885CHRNA7 3124/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.